Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care PopulationByDaniel A. Ollendorf, MPH,Anna N. Peterson, BA,Joseph Doyle, RPh, MBA,Daniel M. Huse, MAMay 1st 2002
